Nalbuphine Hydrochloride (Hospira, Inc.)
Welcome to the PulseAid listing for the Nalbuphine Hydrochloride drug offered from Hospira, Inc.. This Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hospira, Inc. |
| NON-PROPRIETARY NAME: | NALBUPHINE HYDROCHLORIDE |
| SUBSTANCE NAME: | NALBUPHINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] |
| ROUTE: | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2005-03-31 |
| END MARKETING DATE: | 0000-00-00 |
Nalbuphine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nalbuphine Hydrochloride from Hospira, Inc. |
| LABELER NAME: | Hospira, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2005-03-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0409-1463_b51c097c-567a-44ad-bd30-ced09525a7da |
| PRODUCT NDC: | 0409-1463 |
| APPLICATION NUMBER: | ANDA070914 |
Other NALBUPHINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
